China Universal Asset Management Company’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BDTX
DIM
PFSRSONJ
DT
BCMLT
JSSH
BCM
KCM
China Universal Asset Management Company's BDTX Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Black Diamond Therapeutics (BDTX) stake by 9.8% in Q2 2026, selling an estimated $2.42K and leaving 9,120 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #499.
China Universal Asset Management Company first reported a position in BDTX in Q3 2022 and has held it in 4 quarters since. The position peaked at $22.6K in Q4 2025. 16 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.
- China Universal Asset Management Company held 9,120 shares of Black Diamond Therapeutics worth $16.9K as of Q2 2026.
- China Universal Asset Management Company sold 991 Black Diamond Therapeutics shares in Q2 2026, an estimated $2.42K.
- Black Diamond Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #499 holding.
- China Universal Asset Management Company first reported a position in Black Diamond Therapeutics in Q3 2022 and has held it in 4 quarters since.
- China Universal Asset Management Company's Black Diamond Therapeutics position peaked at $22.6K in Q4 2025.
- 16 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.